SCHEMBL4199227

SCHEMBL4199227

Cc1ccc(N(S)C(N)=O)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.38
TP53 P04637 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PARP1 P09874 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALOX5 P09917 2/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
NPC1 O15118 2/20 0.35
MAPT P10636 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
HTT P42858 2/20 0.34
ALDH1A1 P00352 2/20 0.34
RAB9A P51151 1/20 0.34
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11539989 0.82 ALDH1A1 (0.43) MEN1KMT2AKDM4EALOX5SMN1; SMN2
SCHEMBL3604278 0.80 POLB (0.42) MEN1KMT2APARP1KDM4EALOX5
SCHEMBL11348217 0.79 MEN1 (0.39) TDP1TP53MEN1KMT2AKDM4E
SCHEMBL653135 0.77 S100B (0.50) TDP1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL4919799 0.77 SIGMAR1 (0.42) TP53MEN1KMT2AKDM4EALOX5
SCHEMBL15174259 0.76 KDM4E (0.39) MEN1KMT2AKDM4EALOX5SMN1; SMN2
SCHEMBL6114258 0.76 HPGD (0.51) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL11513064 0.75 LMNA (0.41) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL11548076 0.75 SMN1; SMN2 (0.40) MEN1KMT2AKDM4ESMN1; SMN2NPC1
SCHEMBL2749288 0.75 AKR1C3 (0.36) TP53MEN1KMT2APARP1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611109-A4 NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO LTD (JP) 2009-06-24 EP disclosed
EP-1611109-A1 NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-01-04 EP disclosed
WO-2004087680-A1 NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO., LTD. (JP) 2004-10-14 WO disclosed
EP-0397511-B1 Novel cephalosporin compounds and processes for preparation thereof LUCKY LTD (KR) 1996-09-04 EP disclosed
US-5202315-A Antiboiotic LUCKY, LTD. (KR) 1993-04-13 US disclosed
WO-1992008721-A1 NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF LUCKY, LTD. (KR) 1992-05-29 WO disclosed
EP-0397511-A2 Novel cephalosporin compounds and processes for preparation thereof LUCKY, LTD. (KR) 1990-11-14 EP disclosed
US-4816235-A Silver and manganese recovery using acidified thiourea PESIC BATRIC (US) 1989-03-28 US disclosed
US-4778519-A Recovery of precious metals from a thiourea leach PESIC BATRIC (US) 1988-10-18 US disclosed
US-4148799-A Process for the preparation of 2-aryliminothiazoline solutions BAYER AKTIENGESELLSCHAFT (DE) 1979-04-10 US disclosed
US-3994719-A Resins for separating heavy metals consisting of thiourea-group-containing macroporous vinyl aromatic crosslinked matrixes BAYER AKTIENGESELLSCHAFT (DT) 1976-11-30 US disclosed